Categories Uncategorized

Survey Finds Doctors Underestimate Patients’ Comfort with AI-Aided Healthcare

According to a survey conducted by Gallup Center and West Health, most Americans have no problem with artificial intelligence playing a role in their healthcare, as long as doctors remain in control. However, the survey found that the same cannot be said of doctors.

56% of the patients surveyed revealed that they didn’t have a problem with AI playing a role in diagnosis or even treatment decisions if a doctor could still override or change the recommendations made by the AI tool used. This was in sharp contrast to the results of another survey that asked doctors to estimate the percentage of their patients that would be okay with AI being used in their care.

The survey that sought the opinions of doctors found that a small fraction (36%) of the doctors felt most of the patients they handle would be okay with artificial intelligence playing a role in their healthcare. These findings suggest that doctors underestimate the receptiveness of patients to the use of artificial intelligence in healthcare.

That difference also highlights the opportunities that the medical profession has in incorporating AI within their work, as long as human oversight is retained.

This issue of a doctor retaining final say came out strongly in the survey results. Only 9% expressed comfort with AI making decisions without doctor involvement. Joe Daly, the Global Managing Partner of Gallup, said these survey results can be vital in guiding decisions on how AI can be used when it is clear which aspects must still be controlled by humans and which ones patients wouldn’t have a problem if AI took over.

On whether AI could make prescriptions, 45% of the patients surveyed said they would be comfortable as long as a doctor reviewed and signed off on the AI-guided prescriptions. However, if AI was to make the call on a patient’s medication without a doctor being involved, just 11% of the patients polled expressed comfort.

It is clear from the findings of this survey that patients are willing to see AI playing a role in their healthcare but they don’t want the technology to replace their doctors. It is therefore important for the healthcare sector to use utmost care when implementing the integration of AI into systems so that the technology supports the work that healthcare professionals do instead of taking over the work entirely.

The tasks that AI can or cannot be trusted with are likely to be the subject of increasing debate in the months to come across the healthcare sector, and it is likely that discussions on the subject are already taking place within sector players like Astiva Health.

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Wastewater Provides Vital Clues on Community Health Patterns, Study Finds

A study conducted recently in Ohio has found that wastewater can be a vital provider…

4 days ago

Preclinical Study Suggests New Therapy Could Wipe Out Brain Tumors

UC San Francisco-based scientists have developed a new immunotherapy that was successful in wiping out…

5 days ago

MIT Researchers Engineer Donor Immune Cells to Wipe Out Cancer Cells

Immunotherapy has transformed cancer treatment, but the approach still faces challenges like lengthy preparation time…

1 week ago

Expert Explains Why Healthcare Costs are Continuing to Rise in the US

The palpable euphoria surrounding the election of Democratic healthcare professionals to key positions in the…

2 weeks ago

Study Finds That High-Risk Antibiotic is Given to 20% of Patients Having Dental Infections

When a person develops a serious dental infection, the pain can be excruciating, particularly when…

2 weeks ago

Adaptogenics Health Corp. (CSE: ADPT) Eyes Opportunities Beyond Standard Peptides as Policy Opens Pharmacy and Telehealth Channels

Disseminated on behalf of Adaptogenics Health Corp.and may include paid advertising. The federal government is…

2 weeks ago